Drug Trial Radar · NCT00898677
Rizatriptan 5 mg and 10 mg, Sumatriptan 100 mg, and Placebo Comparison Study (0462-030)
Last checked: Nov 19, 2026Latest source record: Feb 3, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,268
Actual
Start
Sep 1995
Primary completion
May 1996
Study completion Sep 1996
Sponsor
- Lead sponsor
- Organon and CoIndustry
- Sponsor type
- Industry
- First posted
- May 12, 2009
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A study to compare rizatriptan 10 mg verse sumatriptan 100 mg in the treatment of migraine attacks and duration of relief provided. This study will also provide additional efficacy data on rizatriptan 5 mg and 10 mg for the treatment of migraine.
Conditions
- Migraine Headache
Interventions
rizatriptan benzoateDrug
single dose administration of 5mg rizatriptan (by Mouth) p.o.
rizatriptan benzoateDrug
single dose administration of 10 mg rizatriptan p.o.
Comparator: sumatriptanDrug
single dose administration of sumatriptan 100 p.o.
Comparator: PlaceboDrug
placebo to rizatriptan
Primary outcomes
What the sponsor says the trial is designed to measure.
- Pain Relief at 2 Hours After DoseTime frame: 2 hours after dose
- Time to Relief Within 2 Hours After DoseTime frame: within 2 hours after dose
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.